Loading stock…

Pure Health Holding PJSC (PUREHEALTH) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Pure Health Holding PJSC

PUREHEALTHMarket cap $8.32BPrice $0.7

Country🇦🇪United Arab Emirates

SectorHealthcare

IndustryHealthcare Services

Runs hospitals, clinics, labs, and pharmacies across the UAE, treating millions of patients yearly. It's the largest healthcare platform in the Middle East, built through aggressive acquisitions rather than organic growth alone.

In Bastion Portfolios?

52W Return+1%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+30%10

Revenue Forecast

Rev CAGR (1y)+12%7

Rev CAGR (3y)+9%6

Rev CAGR (5y)+8%7

Earnings Forecast

EPS Growth Y+1+14%7

EPS Growth Y+2+18%8

EPS Growth Y+3+14%7

Quality

Margins

EBIT Margin10%4

Net Income Margin8%5

Free Cash Flow Margin10%6

Debt

Net Debt/EBITDA2.73

Efficiency

ROE11%5

ROA4%5

Earnings Stability55

GEAR+STRONG73

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)146

P/E Ratio (Forward 3y)108

P/BV1.68

EV Multiples

EV/EBITDA Fwd78

EV/EBIT Fwd127

Yield

Free Cash Flow Yield9.0%9

Dividend Yieldna–

Momentum

Short term

1 month return+5%9

3 month return+20%10

YTD return+11%6

Mid term

Price vs 52wHigh94%9

1 year return-0%5

Long term

3 year return-50%1

5 year return-50%1

Risk Shield

Price Risk

Beta0.57

Volatility32%6

Free Cash Flow

Free Cash Flow Margin10%6

Free Cash Flow Yield9.0%9

Quality

ROCE8%4

Earnings Stability55

Net Debt/EBITDA2.73

02Growth

Is it actually growing, and how fast?

PUREHEALTHPure Health Holding PJSC

Revenue FY25$7.4B

GROWTH RATING↗

STRONG68 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+30%10

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+9%6

Revenue, next 5Y, CAGR+8%7

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+14%7

EPS growth, FY27E+18%8

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 68% of companies worldwide.

Revenue grew 30%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 9%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 8%/yr over five years.7/10

Earnings are set to grow in step with sales (EPS about 14%/yr vs revenue 9%/yr).

WATCH

Revenue grew 30%/yr over the last 3 years; forecasts see it cooling to 9%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

PUREHEALTHPure Health Holding PJSC

Total return Current−51.2%

Price return Current−51.8%

MOMENTUM RATING↗

AVERAGE60 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+5%9

3-month return+20%10

YTD return+11%6

MID & LONG-TERM▾SCORE

% of 52-week high94%9

1-year return-0%5

3-year return-50%1

5-year return-50%1

MOMENTUM ASSESSMENT

STRENGTHS

It's down 0.3% over the past year, now 6% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+5%) and over three months (+20%).

WATCH

Returns sit at the market level so far this year (+11%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-50% over three years and -50% over five), behind 90% of the market.

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Pure Health Holding PJSC. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

PUREHEALTHPure Health Holding PJSC

Revenue FY25$7.4B

GROWTH RATING↗

STRONG68 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+30%10

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+9%6

Revenue, next 5Y, CAGR+8%7

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+14%7

EPS growth, FY27E+18%8

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 68% of companies worldwide.

Revenue grew 30%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 9%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 8%/yr over five years.7/10

Earnings are set to grow in step with sales (EPS about 14%/yr vs revenue 9%/yr).

WATCH

Revenue grew 30%/yr over the last 3 years; forecasts see it cooling to 9%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

PUREHEALTHPure Health Holding PJSC

Total return Current−51.2%

Price return Current−51.8%

MOMENTUM RATING↗

AVERAGE60 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+5%9

3-month return+20%10

YTD return+11%6

MID & LONG-TERM▾SCORE

% of 52-week high94%9

1-year return-0%5

3-year return-50%1

5-year return-50%1

MOMENTUM ASSESSMENT

STRENGTHS

It's down 0.3% over the past year, now 6% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+5%) and over three months (+20%).

WATCH

Returns sit at the market level so far this year (+11%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-50% over three years and -50% over five), behind 90% of the market.

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Pure Health Holding PJSC. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community